Cantel Medical (NYSE: CMD) is one of 104 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare Cantel Medical to related businesses based on the strength of its analyst recommendations, profitability, dividends, risk, institutional ownership, earnings and valuation.
Volatility & Risk
Cantel Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, Cantel Medical’s peers have a beta of 0.80, indicating that their average share price is 20% less volatile than the S&P 500.
This table compares Cantel Medical and its peers top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Cantel Medical||$770.16 million||$71.37 million||52.57|
|Cantel Medical Competitors||$1.54 billion||$111.80 million||-145.51|
Cantel Medical’s peers have higher revenue and earnings than Cantel Medical. Cantel Medical is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
This table compares Cantel Medical and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Cantel Medical Competitors||-62.26%||-47.35%||-18.28%|
This is a breakdown of current recommendations and price targets for Cantel Medical and its peers, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Cantel Medical Competitors||494||1877||3743||115||2.56|
Cantel Medical presently has a consensus target price of $92.00, indicating a potential downside of 15.87%. As a group, “Surgical & medical instruments” companies have a potential upside of 12.03%. Given Cantel Medical’s peers stronger consensus rating and higher possible upside, analysts plainly believe Cantel Medical has less favorable growth aspects than its peers.
Cantel Medical pays an annual dividend of $0.17 per share and has a dividend yield of 0.2%. Cantel Medical pays out 8.2% of its earnings in the form of a dividend. As a group, “Surgical & medical instruments” companies pay a dividend yield of 1.2% and pay out 32.7% of their earnings in the form of a dividend.
Institutional and Insider Ownership
85.2% of Cantel Medical shares are owned by institutional investors. Comparatively, 48.0% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 12.3% of Cantel Medical shares are owned by company insiders. Comparatively, 16.1% of shares of all “Surgical & medical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Cantel Medical peers beat Cantel Medical on 8 of the 15 factors compared.
Cantel Medical Company Profile
Cantel Medical Corp. provides infection prevention products and services for the healthcare market worldwide. The company operates through four segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services. The Water Purification and Filtration segment provides water purification systems; bicarbonate systems; hollow fiber filters; filtration and separation, liquid disinfectants and cold sterilization, and dry fog products; and room temperature sterilizers for the dialysis and specific healthcare applications, research laboratories and pharmaceutical, food and beverage, and commercial industrial customers. The Healthcare Disposables segment offers biological and chemical integrators, sterilization pouches, towels, bibs, tray liners and sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, shields, hand sanitizers, germicidal wipes, surface disinfectants, saliva ejectors, evacuator tips and plastic cups, and prophy angles and pastes, as well as waterline treatment products for maintaining safe dental unit waterlines. The Dialysis segment provides medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates, and other supplies for renal dialysis. The company sells its products through its direct distribution network in the United States; and directly or under third-party distribution agreements internationally. The company was founded in 1963 and is headquartered in Little Falls, New Jersey.
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.